FindTrial
Sign In

Comparison of the analgesic effects of ropivacaine, combined with sufentanil, to pethidine on blood biomarkers of pain and stress after caesarian section.

Comparison of the analgesic effects of ropivacaine, combined with sufentanil, to pethidine on blood biomarkers of pain and stress after caesarian section.

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR1800019621
Enrollment
Unknown
Registered
2018-11-20
Start date
2018-12-01
Completion date
Unknown
Last updated
2018-11-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

caerean section

Interventions

NC?:Intramuscular injection Piperidine for analgesia
RF?:Ropivacaine combined with sufentanil for patient-controlled epidural analgesia

Sponsors

Fujian Provincial Maternity and Children Hospital
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
20 Years to 45 Years

Inclusion criteria

Inclusion criteria: The patients of cerean section, American Society of Anesthesiologists Physical status I or II; term delivery; single live delivery; and no history of epidural anesthesia. Women with an allergy to ropivacaine and/or sufentanil and those with systemic infectious diseases, hyperthyroidism, hypothyroidism, and other diseases affecting basic metabolism, were not included.

Exclusion criteria

Exclusion criteria: 1. allergic to local anesthetic; 2. abnormal coagulation function; 3. abnormal liver kidney function; 4. history of nerve or muscle abnormalities; 5. mental illness; 6. unable to understor to express VAS pain scores correctly;

Design outcomes

Primary

MeasureTime frame
NPY;SP;NGF;COR;CORT;Ang-I, Ang-II;NE;ACTH;DA;—

Contacts

Public ContactMin Zhou

Department of Anesthesiology, Fujian Provincial Maternity and Children Hospital

zm405@163.com+86 13850101696

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026